Fassio, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 2.217
EU - Europa 2.026
AS - Asia 766
SA - Sud America 20
AF - Africa 10
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.050
Nazione #
US - Stati Uniti d'America 2.204
CN - Cina 670
GB - Regno Unito 505
DE - Germania 327
IT - Italia 288
IE - Irlanda 248
SE - Svezia 247
FR - Francia 208
FI - Finlandia 70
RU - Federazione Russa 45
UA - Ucraina 30
VN - Vietnam 29
BR - Brasile 13
CA - Canada 13
HK - Hong Kong 13
NL - Olanda 10
AT - Austria 9
RO - Romania 9
BE - Belgio 8
IR - Iran 8
KR - Corea 8
AU - Australia 7
TR - Turchia 7
IN - India 6
EG - Egitto 5
PT - Portogallo 5
QA - Qatar 5
SG - Singapore 5
CH - Svizzera 4
JP - Giappone 4
AR - Argentina 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
ES - Italia 2
IQ - Iraq 2
PH - Filippine 2
SI - Slovenia 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
BD - Bangladesh 1
BO - Bolivia 1
DK - Danimarca 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HR - Croazia 1
KE - Kenya 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 5.050
Città #
Chandler 609
Southend 484
Dublin 243
Ashburn 182
Jacksonville 130
Beijing 127
Redmond 97
Princeton 84
Lawrence 83
Wilmington 78
New York 75
Ann Arbor 62
Jinan 59
Shenyang 55
Verona 54
Woodbridge 52
Helsinki 51
Houston 50
Nanjing 46
Bologna 41
Sindelfingen 39
Hebei 34
Tianjin 32
Zhengzhou 29
Haikou 27
Washington 26
Changsha 24
Hangzhou 23
Ningbo 20
Seattle 20
San Francisco 17
Fairfield 15
Jiaxing 15
Redwood City 15
Taiyuan 15
Dong Ket 13
Nanchang 13
Taizhou 13
Guangzhou 12
Chicago 11
Norwalk 11
Milan 10
Nürnberg 10
Vienna 9
Brussels 8
Falls Church 8
Florianópolis 8
Bârlad 7
Dearborn 7
Dongguan 7
Lanzhou 7
Boydton 6
Detroit 6
Fuzhou 6
Hong Kong 6
Rome 6
Seo-gu 6
Toronto 6
Düsseldorf 5
Esslingen am Neckar 5
Falkenstein 5
Bari 4
Cagliari 4
Easton 4
Miami 4
Shanghai 4
Singapore 4
Trieste 4
Biandronno 3
Canberra 3
Central 3
Genova 3
Kemerovo 3
Lancaster 3
Las Vegas 3
Mansehra 3
Mehlingen 3
Riva 3
São Paulo 3
Tarcento 3
Tokyo 3
Venice 3
Zanjan 3
Acquaviva Picena 2
Bergamo 2
Brescia 2
Buenos Aires 2
Calais 2
Cambridge 2
Cannes 2
Cascina 2
Chapel Hill 2
Chennai 2
Chiampo 2
Clearwater 2
Des Moines 2
Hyderabad 2
Isola della Scala 2
Karbala 2
Lappeenranta 2
Totale 3.331
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 240
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 110
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 105
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 103
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 98
Anti-CCP antibodies and bone 94
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 88
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 86
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 86
Drug-induced osteonecrosis of the jaw: the state of the art 85
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 83
Periostin: The bone and beyond 83
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 80
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 80
Duration of treatment for osteoporosis 79
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 78
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 78
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 77
Rheumatoid arthritis, γδ T cells and bisphosphonates 76
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 74
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 73
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 73
The obesity paradox and osteoporosis 72
Effects of secukinumab on serum adipocytokines: preliminary data 67
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 66
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 65
Vitamin D: not just bone, but also immunity 64
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 64
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 64
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 62
Association between environmental air pollution and rheumatoid arthritis flares 62
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 61
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 61
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 61
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 60
Insight into the WNT system and its drug related response. 59
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 59
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 57
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 57
Correction to: The obesity paradox and osteoporosis 56
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 55
Osteoporosis in Rheumatic Diseases 53
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 52
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 52
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 52
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 49
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 49
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 47
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 47
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 47
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 47
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes 46
Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus 45
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 45
Radiological features of knee joint synovial chondromatosis 44
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 44
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 43
Calcium and vitamin D supplementation: when and why 43
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 42
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 42
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 42
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 42
Wnt pathway involvement and its response to treatment in the development of bone damage in different inflammatory and non-inflammatory rheumatic contidions 41
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 40
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 40
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 40
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 39
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 39
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 38
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 38
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 38
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 38
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 37
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 36
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 36
Nail ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review 33
Ultrasonographic detection, definition and quantification of soft tissue oedema in psoriatic dactylitis 33
Pharmacological management of osteoporosis in postmenopausal women: The current state of the art 33
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 33
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 31
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 31
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 31
Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) 28
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 24
Vitamin D and Osteogenesis Imperfecta in Pediatrics 23
Association between acute exposure to environmental air pollution and fragility hip fractures 23
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 23
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 21
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 19
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 17
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 17
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 16
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 16
Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases (iRMD) patients treated with low dose glucocorticoids, but is prevented by anti-osteoporosis medications 14
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 14
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting 13
Bone health status evaluation in men by means of REMS technology 11
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 11
Vitamin D: no efficacy without deficiency. What?s new? 11
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 10
Totale 5.210
Categoria #
all - tutte 19.805
article - articoli 19.334
book - libri 0
conference - conferenze 264
curatela - curatele 0
other - altro 207
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 5 3 6
2019/2020483 50 15 18 51 54 66 53 8 42 34 30 62
2020/2021717 105 120 26 118 76 50 42 5 52 8 64 51
2021/2022692 62 164 12 43 23 23 19 31 54 24 36 201
2022/20231.724 98 175 142 329 157 400 17 87 206 28 66 19
2023/2024864 37 89 101 124 110 220 60 59 30 34 0 0
Totale 5.264